CRP and left ventricular hypertrophy: In addition, valsartan therapy for 8 months reduced CRP by 39% in hypertensive patients with left ventricular hypertrophy [21] or with other cardiovascular risk factors [22], while 3 months of irbesartan therapy for patients with coronary artery disease significantly reduced the plasma CRP level [23].